Bharti Sapra

Lorsque les effets d'un m dicament sont modifi s par la pr sence d'un autre m dicament, d'un produit base de plantes, d'une boisson ou d'un aliment, on parle d'interaction m dicamenteuse. Le r sultat peut tre n faste si l'interaction augmente la toxicit du m dicament. Plus un patient prend de m dicaments, plus la probabilit qu'un effet ind sirable se produise est grande. Il est g n ralement difficile d'identifier une interaction en raison de la variabilit individuelle. En th orie, de nombreuses raisons et facteurs peuvent d terminer si une interaction se produit ou non. Cependant, dans la pratique, il est toujours tr s difficile de la pr voir. La solution simple ce probl me pratique est de choisir une alternative sans interaction avec pr caution, mais ce n'est pas toujours possible. Dans certains cas, le niveau d'interaction peut tre minimis de mani re intelligente en ajustant les dosages. De cette fa on, les interactions li es la dose peuvent tre r duites. Il est raisonnablement impossible de conserver des informations et des informations sur toutes les interactions connues et cliniquement importantes, c'est pourquoi ce livre sur les analg siques a t produit.

Wenn sich die Wirkungen eines Arzneimittels durch die Anwesenheit eines anderen Arzneimittels/eines anderen pflanzlichen Produkts/eines anderen Medikaments, eines Lebensmittels, eines Getr nks usw. ver ndern, spricht man von einer Arzneimittelwechselwirkung. Das Ergebnis kann sch dlich sein, wenn die Wechselwirkung die Toxizit t des Arzneimittels erh ht. Je mehr Arzneimittel ein Patient einnimmt, desto gr er ist die Wahrscheinlichkeit, dass eine unerw nschte Reaktion auftritt. In der Regel ist es schwierig, eine Wechselwirkung zu erkennen, da sie individuell verschieden ist. Theoretisch k nnen viele Gr nde und Faktoren daf r verantwortlich sein, ob eine Wechselwirkung auftritt oder nicht. In der Praxis ist es jedoch immer noch sehr schwierig, dies vorherzusagen. Der unkomplizierte Ausweg aus diesem praktischen Problem besteht darin, vorsorglich eine nicht interagierende Alternative zu w hlen, was jedoch nicht immer m glich ist. Das Ausma der Wechselwirkung kann in bestimmten F llen durch eine Anpassung der Dosierung sinnvoll minimiert werden. Auf diese Weise k nnen die dosisabh ngigen Wechselwirkungen reduziert werden. Es ist einigerma en unpraktikabel, Informationen und Vorkommen ber alle bekannten klinisch wichtigen Wechselwirkungen zu speichern, weshalb dieses Buch ber Analgetika erstellt wurde.

Quando os efeitos de um medicamento mudam devido presen a de outro medicamento/produto/medicina, comida, bebida, etc., isto designado como interac o medicamentosa. O resultado pode ser prejudicial se a interac o aumentar a toxicidade do f rmaco. Quanto mais f rmacos um paciente tomar, maior a probabilidade de ocorr ncia de uma reac o adversa. Normalmente dif cil identificar uma interac o devido variabilidade individual. Teoricamente, muitas raz es e factores podem estabelecer se uma interac o ocorre ou n o. No entanto, praticamente ainda muito dif cil prever o mesmo. A solu o sem complica es para este problema pr tico escolher uma alternativa n o-interactiva com precau o, no entanto, nem sempre poss vel. O n vel de interac o pode ser minimizado em certos casos de forma intelig vel, ajustando as dosagens. Desta forma, as interac es relacionadas com a dosagem podem ser reduzidas. razoavelmente impratic vel reter informa o e ocorr ncia sobre todas as interac es clinicamente importantes conhecidas, raz o pela qual este livro sobre analg sicos foi produzido.

Quando gli effetti di un farmaco cambiano a causa della presenza di un altro farmaco/prodotto erboristico/medicina, cibo, bevanda ecc. Il risultato pu essere dannoso se l'interazione aumenta la tossicit del farmaco. Pi farmaci prende un paziente, maggiore la probabilit che si verifichi una reazione avversa. Di solito difficile identificare un'interazione a causa della variabilit individuale. Teoricamente, molte ragioni e fattori possono stabilire se un'interazione si verifica o meno. Tuttavia, praticamente ancora molto difficile prevedere la stessa. La via d'uscita non complicata a questo problema pratico scegliere un'alternativa non interagente con precauzione, tuttavia, non sempre possibile. Il livello di interazione pu essere minimizzato in certi casi in modo intelligente regolando i dosaggi. In questo modo, le interazioni legate alla dose possono essere ridotte. ragionevolmente impraticabile conservare informazioni e occorrenze su tutte le interazioni clinicamente importanti conosciute, ecco perch stato prodotto questo libro sugli analgesici.

When the effects of one drug change due to the presence of another drug/herbal product/medicine, food, drink etc. this is termed as drug interaction. The result can be injurious if the interaction augments the toxicity of the drug. The more drugs a patient takes, the greater the likelihood that an adverse reaction will occur. Usually it is difficult to identify an interaction because of individual variability. Theoretically, many reasons and factors can establish whether an interaction occurs or not. However, practically it is still very difficult to predict the same. The uncomplicated way out to this practical problem is to choose a non-interacting alternative with precaution, however, it is not always possible. The level of interaction can be minimized in certain cases intelligibly by adjusting the dosages. In this way, the dose-related interactions can be reduced. It is reasonably impracticable to retain information and occurrence about all the known clinically important interactions that is why this book about analgesics has been produced.

Chitosan is the deacetylated form of chitin. Generally, the substance becomes soluble in dilute acids when the degree of deacetylation is more than 50%. The solubility of chitosan in dilute acids is often needed to be modified when specific drug release properties have to be tailored into the dosage form. The available toxicological data on chitosan and its modified forms appears to indicate its safety for oral use because high doses have been found to be tolerated well in rodents and rabbits. However, its local action as a haemostatic together with its ability to activate macrophages and cause cytokine release may require a careful assessment of its safety for parenteral use. This book offers the dynamics of chitosan's detailed composition.